Non-invasive ventilation (NIV) is considered fi rst-line intervention for diff erent causes of acute respiratory failure [1] . However, Rello and colleagues [2] show high rates of NIV failure in pandemic Infl uenza A/H1N1 virus infection (PH1N1).
Non-invasive ventilation (NIV) is considered fi rst-line intervention for diff erent causes of acute respiratory failure [1] . However, Rello and colleagues [2] show high rates of NIV failure in pandemic Infl uenza A/H1N1 virus infection (PH1N1).
We describe a patient with PH1N1 in whom NIV was eff ective. A 53-year-old male was admitted in November 2009 with cough, dyspnea, and hemoptysis. His temperature was 38.9°C, he was tachypneic, with diff use rhonchi and bilateral crackles, and oxygen saturation was 96% (4 L/min oxygen). Arterial partial pressure of oxygen (PaO 2 ) and arterial partial pressure of carbon dioxide (PaCO 2 ) were 76 and 23 mm Hg, respectively. Creatine kinase (2,278 U/L) and brain natriuretic peptide (3,544 pg/ mL) were increased. Acute myocardial infarction was excluded. Chest x-ray showed bilateral interstitial infi ltrates and cardiomegaly. Echocardiogram showed severe left ventricular systolic dysfunction. PH1N1 pneumonia was suspected, and oseltamivir was administered in association with antibiotics and diuretics. On day 2, a nasopharyngeal swab was positive for PH1N1. Th e patient was subsequently transferred to a negativepressure ward. He was still tachypneic, with basal crackles and a PaO 2 /fraction of inspired oxygen ( Recently, Djibré and colleagues [3] demonstrated the eff ectiveness of NIV in acute respiratory distress syndrome related to PH1N1 pneumonia. Our case further supports its role in a hypoxemic patient with cardiogenic pulmonary edema and PH1N1 pneumonitis. 
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We appreciate the interest from Winck and Marinho in our article and their insightful observations regarding non-invasive ventilation (NIV) in severe infl uenza A (H1N1)v. Th e use of NIV in hypoxemic respiratory failure is controversial, and the etiology of hypoxemia appears to be an important determinant of its success. A metaanalysis [4] suggests that non-invasive positive-pressure ventila tion does not decrease the need for intubation, so there is not enough evidence to support its use in acute respira tory distress syndrome. Our experience [2] is consistent with other reports [5, 6] ; 25% to 30% of patients were non-invasively ventilated on admission, but 70% to 85% of these patients required subsequent intubation and invasive ventilation. Th ere are only a few patients with H1N1-related respiratory failure who seem to benefi t from NIV alone, so it should be reserved for patients with milder disease. Guidelines endorsed by the European Respiratory Society and European Society of Intensive Care Medicine [7] conclude that, as a general rule, NIV not be recommended as an alternative to invasive ventilation in patients aff ected by H1N1. In spite of this, selected patients with hypoxemia and additional cardiac compromise (severe left ventri cular systolic dysfunction)
